Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use
OptimalDosages

NAD+ / MOTS-c / 5-Amino-1MQ Blend Dosage & Reconstitution

NAD+ 100 mg + MOTS-c 10 mg + 5-Amino-1MQ 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

24 mg/mL · 24000 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — NAD+ / MOTS-c / 5-Amino-1MQ BlendYour Answer

—
25Draw To This Line
0.25That's This Many mL
20Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 25
120 mg ÷ 5 mL = 24 mg/mL  →  6 mg ÷ 24 mg/mL = 0.25 mL  →  × 100 = 25 units—
Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 20 doses.

2Week-By-Week Plan — NAD+ / MOTS-c / 5-Amino-1MQ Blend

Build up to 1 mg MOTS-c daily
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Week 1–2 start 3 mg 1× daily (0.25 mg MOTS-c / 2.5 mg NAD+) 0.125 mL 12.5 u 40 doses
Week 3–4 6 mg 1× daily (0.5 mg MOTS-c / 5 mg NAD+) 0.25 mL 25 u 20 doses
Week 5–6 9 mg 1× daily (0.75 mg MOTS-c / 7.5 mg NAD+) 0.375 mL 37.5 u 13 doses
Target 12 mg 1× daily (1 mg MOTS-c / 10 mg NAD+) 0.5 mL 50 u 10 doses
Weeks until the top dose
6 weeks
Peptide used getting there
252 mg
Vials you'll need
3 × 120 mg
Once you're at the top dose
336 mg / 4 wk · 2.8 vials
Where this plan came from
An OptimalDosages protocol
Where this came from: Anchored to a 1 mg daily MOTS-c target, stepped up in quarter-milligram increments every two weeks. The blend is dosed on its total weight, so each step raises all three components together. Figures in brackets are what each step delivers of MOTS-c and NAD+. A vial runs roughly 10 days once you reach the target.

3Common Doses — NAD+ / MOTS-c / 5-Amino-1MQ Blend

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 3 mg daily 0.125 mL 12.5 u 14 42 mg
Weeks 3–4 6 mg daily 0.25 mL 25 u 14 84 mg
Weeks 5–6 9 mg daily 0.375 mL 37.5 u 14 126 mg
Week 7 onward
per 4 weeks from here on		 12 mg daily 0.5 mL 50 u 28 336 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About NAD+ / MOTS-c / 5-Amino-1MQ BlendAbout This Peptide

Multi-Compound Blends
Also known as
NAD+ 100 mg + MOTS-c 10 mg + 5-Amino-1MQ 10 mg
Class
Multi-Compound Blends
Route
Subcutaneous
Half-life
Mixed
Evidence tier
Preclinical

A metabolic combination in a 120 mg vial, dosed daily and anchored to MOTS-c. MOTS-c is 8.3% of the contents, so a 1 mg daily MOTS-c dose means 12 mg of blend — which also delivers 10 mg of NAD+ and 1 mg of 5-Amino-1MQ. Because the ratio is fixed, anchoring to MOTS-c puts the other two low against their own figures: NAD+ is reported at 50–100 mg per dose and 5-Amino-1MQ at 50–150 mg orally. At 1 mg MOTS-c daily a vial runs about 10 days.

Buy NAD+ / MOTS-c / 5-Amino-1MQ Blendthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
See component entries: NAD+, MOTS-c, 5-Amino-1MQ No blend-specific literature exists
Nothing has tested these three together. The schedule above is built around a 1 mg daily MOTS-c target rather than any published combination protocol.
Find on PubMed ↗

Newest Studies — —

—
Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

Semax / Selank Blend

An equal-parts pairing of the two Russian-registered neuropeptides — 5 mg of each in a 10 mg vial, so every dose splits evenly dow…

Retatrutide / Cagrilintide Blend

Equal parts of a triple incretin agonist and an amylin analogue — 5 mg of each in a 10 mg vial, once weekly. The thing to understa…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.